1. Home
  2. KE vs SPRY Comparison

KE vs SPRY Comparison

Compare KE & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$26.17

Market Cap

564.2M

Sector

Technology

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$4.86

Market Cap

558.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
SPRY
Founded
1961
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
564.2M
558.9M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
KE
SPRY
Price
$26.17
$4.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$28.00
$40.00
AVG Volume (30 Days)
206.6K
1.4M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
66.18
N/A
EPS
1.13
N/A
Revenue
$1,431,378,000.00
$84,278,000.00
Revenue This Year
N/A
$87.40
Revenue Next Year
$4.57
$81.64
P/E Ratio
$22.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.60
$4.91
52 Week High
$33.19
$13.15

Technical Indicators

Market Signals
Indicator
KE
SPRY
Relative Strength Index (RSI) 53.09 34.83
Support Level $23.42 $5.04
Resistance Level $26.85 $8.61
Average True Range (ATR) 0.70 0.26
MACD 0.17 -0.03
Stochastic Oscillator 83.15 3.64

Price Performance

Historical Comparison
KE
SPRY

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: